- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07937527
Effects of Rhodiola Rosea Supplementation on Anaerobic Performance and Blood Lactate in Trained Men
Effects of Short-term Rhodiola Rosea Supplementation on Anaerobic Performance and Serial Post-exercise Blood Lactate Responses in Trained Men: A Randomized, Double-blind, Placebo-controlled Crossover Trial
This study aimed to investigate the effects of short-term Rhodiola rosea supplementation on anaerobic exercise performance and blood lactate responses during post-exercise recovery in trained male athletes.
The study used a randomized, double-blind, placebo-controlled crossover design involving 23 trained men. Each participant completed two experimental conditions: Rhodiola rosea supplementation and placebo, administered in a randomized order with a 5-day washout period between conditions.
During the Rhodiola rosea condition, participants received 1,500 mg per day for three consecutive days, followed by an additional 500 mg dose 30 minutes before exercise testing. The placebo condition followed an identical administration schedule without the active supplement.
Following each supplementation condition, participants performed a 30-second Wingate Anaerobic Test to assess anaerobic performance. Blood lactate concentrations were measured before exercise and at 3, 10, and 20 minutes after exercise.
The study was designed to determine whether short-term Rhodiola rosea supplementation influences maximal anaerobic performance and blood lactate concentrations during recovery from high-intensity exercise.
Descripción general del estudio
Estado
Intervención / Tratamiento
Descripción detallada
Rhodiola rosea is a plant-derived supplement containing bioactive compounds, including rosavins and salidroside, that have been investigated for their potential effects on physical performance, fatigue, and exercise-related physiological responses. Although previous research has examined the effects of Rhodiola rosea on different exercise modalities, evidence regarding its influence on anaerobic performance and serial blood lactate responses following a single bout of high-intensity exercise remains limited.
This study investigated whether short-term Rhodiola rosea supplementation affects performance during a 30-second Wingate Anaerobic Test (WAnT-30) and blood lactate concentrations during subsequent recovery.
The study employed a randomized, double-blind, placebo-controlled crossover design. Twenty-three trained male athletes completed both supplementation conditions in a randomized sequence. Participants received either Rhodiola rosea or placebo during the first experimental period and the alternate condition during the second period. A 5-day supplement-free washout interval separated the two supplementation periods.
The Rhodiola rosea supplementation protocol consisted of 1,500 mg daily for three consecutive days, administered in three separate 500 mg doses, followed by an additional 500 mg dose 30 minutes before the exercise test. The placebo consisted of an identically flavored non-caloric beverage without active supplementation. Both preparations were administered under standardized conditions to maintain blinding.
Following each supplementation period, participants completed a standardized warm-up and performed a maximal 30-second Wingate test using a cycle ergometer. Anaerobic performance variables included peak power, relative peak power, mean power, total work, cadence at peak power, and rate of fatigue.
Capillary blood lactate concentrations were assessed at rest and at 3, 10, and 20 minutes following the Wingate test. Participants remained seated throughout the post-exercise recovery period.
Dietary intake, physical activity, caffeine consumption, and testing conditions were standardized as far as possible to minimize potential confounding effects.
The study was designed to evaluate the effects of short-term Rhodiola rosea supplementation on maximal anaerobic performance and post-exercise blood lactate responses compared with placebo.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Karaman
-
Karaman, Karaman, Turquía (Türkiye), 70200
- Faculty of Sports Sciences Exercise Physiology Laboratory
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Healthy male athletes aged 18 years or older.
- Regular participation in sport-specific training at least three times per week.
- Active participation in organized competitive sports.
- Engagement in structured training aimed at improving athletic performance.
- Regular participation in lower-body resistance training as part of habitual training programs.
- Previous experience with submaximal exercise testing on a cycle ergometer.
- No musculoskeletal injuries or medical conditions that could affect exercise performance.
- Maintenance of regular training during the month preceding the study.
- Voluntary participation and provision of written informed consent.
Exclusion Criteria:
- Previous use of Rhodiola rosea supplementation.
- Use of any ergogenic supplements within one week before the beginning of the study or during the experimental period.
- History of lower-limb surgery within the previous 12 months.
- Presence of musculoskeletal injuries or medical conditions that could interfere with exercise performance.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Ciencia básica
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación cruzada
- Enmascaramiento: Doble
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Rhodiola rosea Followed by Placebo
Subjects assigned to this sequence received Rhodiola rosea supplementation during the first experimental period, followed by placebo during the second period. Rhodiola rosea was administered at 1,500 mg/day for three consecutive days, with an additional 500 mg dose 30 minutes before the Wingate test. A 5-day supplement-free washout period separated the two experimental periods. Twelve subjects completed this sequence. |
Rhodiola rosea extract (Solgar Rhodiola Root Extract, Solgar Inc., USA), standardized to 3% rosavins and 1% salidroside, was administered at 1,500 mg/day for three consecutive days (500 mg three times daily), followed by an additional 500 mg dose 30 minutes before the Wingate Anaerobic Test. The total dose was 5,000 mg per experimental period. The supplement was administered in a non-caloric mango-flavored beverage. The placebo consisted of an identical non-caloric mango-flavored beverage without Rhodiola rosea extract or any other active supplement. It was administered according to the same schedule as the active supplementation condition to maintain blinding. |
|
Experimental: Placebo Followed by Rhodiola rosea
Subjects assigned to this sequence received placebo during the first experimental period, followed by Rhodiola rosea supplementation during the second period. The placebo followed the same administration schedule as the active supplementation condition but contained no Rhodiola rosea extract. A 5-day supplement-free washout period separated the two experimental periods. Eleven subjects completed this sequence. |
Rhodiola rosea extract (Solgar Rhodiola Root Extract, Solgar Inc., USA), standardized to 3% rosavins and 1% salidroside, was administered at 1,500 mg/day for three consecutive days (500 mg three times daily), followed by an additional 500 mg dose 30 minutes before the Wingate Anaerobic Test. The total dose was 5,000 mg per experimental period. The supplement was administered in a non-caloric mango-flavored beverage. The placebo consisted of an identical non-caloric mango-flavored beverage without Rhodiola rosea extract or any other active supplement. It was administered according to the same schedule as the active supplementation condition to maintain blinding. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Peak Power During the 30-Second Wingate Anaerobic Test
Periodo de tiempo: During the 30-second Wingate test at the end of each 4-day supplementation period
|
Peak power (W) was measured during the 30-second Wingate Anaerobic Test using a cycle ergometer (Lode Excalibur Sport). The highest power output achieved during the test was recorded and compared between the Rhodiola rosea and placebo conditions. |
During the 30-second Wingate test at the end of each 4-day supplementation period
|
|
Post-Exercise Blood Lactate Concentration
Periodo de tiempo: At rest before exercise and at 3, 10, and 20 minutes post-exercise, following each supplementation period
|
Capillary blood lactate concentration (mmol/L) was measured using a portable lactate analyzer (Lactate Scout Sport) at rest and at 3, 10, and 20 minutes after the 30-second Wingate Anaerobic Test. Blood lactate concentrations were compared between the Rhodiola rosea and placebo conditions at each measurement time point. |
At rest before exercise and at 3, 10, and 20 minutes post-exercise, following each supplementation period
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Relative Peak Power During the 30-Second Wingate Anaerobic Test
Periodo de tiempo: During the 30-second Wingate test at the end of each 4-day supplementation period
|
Relative peak power (W/kg) was calculated by normalizing the highest power output achieved during the 30-second Wingate Anaerobic Test to the subject's body mass. Values were compared between the Rhodiola rosea and placebo conditions. |
During the 30-second Wingate test at the end of each 4-day supplementation period
|
|
Mean Power During the 30-Second Wingate Anaerobic Test
Periodo de tiempo: During the 30-second Wingate test at the end of each 4-day supplementation period
|
Mean power (W) was determined as the average mechanical power output generated throughout the 30-second Wingate Anaerobic Test. Values were obtained from the cycle ergometer software and compared between the Rhodiola rosea and placebo conditions. |
During the 30-second Wingate test at the end of each 4-day supplementation period
|
|
Total Work During the 30-Second Wingate Anaerobic Test
Periodo de tiempo: During the 30-second Wingate test at the end of each 4-day supplementation period
|
Total work (kJ) was determined as the cumulative mechanical work performed throughout the 30-second Wingate Anaerobic Test. Values were derived from the cycle ergometer software and compared between the Rhodiola rosea and placebo conditions. |
During the 30-second Wingate test at the end of each 4-day supplementation period
|
|
Cadence at Peak Power During the 30-Second Wingate Anaerobic Test
Periodo de tiempo: During the 30-second Wingate test at the end of each 4-day supplementation period
|
Cadence at peak power (rpm) was recorded as the pedaling rate corresponding to the highest power output achieved during the 30-second Wingate Anaerobic Test. Values were obtained from the cycle ergometer software and compared between the Rhodiola rosea and placebo conditions. |
During the 30-second Wingate test at the end of each 4-day supplementation period
|
|
Rate of Fatigue During the 30-Second Wingate Anaerobic Test
Periodo de tiempo: During the 30-second Wingate test at the end of each 4-day supplementation period
|
Rate of fatigue (%) was obtained from the cycle ergometer software as an indicator of the relative decline in power output during the 30-second Wingate Anaerobic Test. Values were compared between the Rhodiola rosea and placebo conditions. |
During the 30-second Wingate test at the end of each 4-day supplementation period
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Yücel Makaracı, PhD, Karamanoğlu Mehmetbey University
Publicaciones y enlaces útiles
Publicaciones Generales
- Jowko E, Sadowski J, Dlugolecka B, Gierczuk D, Opaszowski B, Cieslinski I. Effects of Rhodiola rosea supplementation on mental performance, physical capacity, and oxidative stress biomarkers in healthy men. J Sport Health Sci. 2018 Oct;7(4):473-480. doi: 10.1016/j.jshs.2016.05.005. Epub 2016 May 20.
- Williams TD, Langley HN, Roberson CC, Rogers RR, Ballmann CG. Effects of Short-Term Golden Root Extract (Rhodiola rosea) Supplementation on Resistance Exercise Performance. Int J Environ Res Public Health. 2021 Jun 29;18(13):6953. doi: 10.3390/ijerph18136953.
- Ballmann CG, Maze SB, Wells AC, Marshall MM, Rogers RR. Effects of short-term Rhodiola Rosea (Golden Root Extract) supplementation on anaerobic exercise performance. J Sports Sci. 2019 May;37(9):998-1003. doi: 10.1080/02640414.2018.1538028. Epub 2018 Oct 29.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- KMU-09-2025/153
- 15-YL-25 (Otro número de subvención/financiamiento: Karamanoğlu Mehmetbey University (KMU) Scientific 645 Research Projects (BAP) Unit)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
De-identified individual participant data may be made available from the corresponding author upon reasonable request. Data will not be publicly accessible due to participant privacy considerations. Each request will be evaluated individually based on its scientific purpose, ethical considerations, and applicable data protection requirements. Data sharing will be subject to appropriate safeguards to protect participant confidentiality.
Marco de tiempo para compartir IPD
Following publication of the study results, upon reasonable request.
Criterios de acceso compartido de IPD
Qualified researchers may request access to de-identified individual participant data by contacting the corresponding author. Each request will be evaluated individually based on its scientific purpose, methodological justification, and compliance with applicable ethical and data protection requirements. Data may be shared upon reasonable request, provided that participant confidentiality and privacy are adequately protected.
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .